CVS Health Corp
XMUN:CVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (0.2), the stock would be worth €62.21 (4% downside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.2 | €64.69 |
0%
|
| 3-Year Average | 0.2 | €62.21 |
-4%
|
| 5-Year Average | 0.3 | €69.02 |
+7%
|
| Industry Average | 1.7 | €452.79 |
+600%
|
| Country Average | 2.4 | €632.07 |
+877%
|
Forward P/S
Today’s price vs future revenue
| Today's Market Cap | Revenue | Forward P/S | ||
|---|---|---|---|---|
|
€93.9B
|
/ |
Jan 2026
$402.1B
|
= |
|
|
€93.9B
|
/ |
Dec 2026
$409.3B
|
= |
|
|
€93.9B
|
/ |
Dec 2027
$428.5B
|
= |
|
|
€93.9B
|
/ |
Dec 2028
$448.7B
|
= |
|
Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
CVS Health Corp
XMUN:CVS
|
100.2B EUR | 0.2 | 56.7 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
68.5B EUR | 0.3 | 13.2 | |
| US |
|
Cigna Corp
NYSE:CI
|
73.7B USD | 0.3 | 12.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 1.2 | 23.6 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
22.9B EUR | 1 | 17.9 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.1B USD | 2 | 21.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.8B USD | 1.6 | 24.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.9B EUR | 0.6 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.5B USD | 11.7 | -27.6 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD | 0.8 | 14.2 | |
| US |
|
Brightspring Health Services Inc
NASDAQ:BTSG
|
9.1B USD | 0 | 0 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.2 |
| Median | 2.4 |
| 70th Percentile | 4.1 |
| Max | 4 613 274.2 |
Other Multiples
CVS Health Corp
Glance View
CVS Health Corporation stands as a pivotal player in the healthcare landscape, tracing its roots back to the early 1960s as a modest chain of health and beauty stores. Evolving through strategic acquisitions and visionary leadership, it burgeoned into one of America’s foremost health solutions providers. The company operates through several segments, each contributing to a comprehensive healthcare ecosystem. Retail/LTC, its retail division, oversees a vast network of pharmacies nationwide, capitalizing on its trusted brand to serve millions of customers with prescriptions, over-the-counter medications, and everyday essentials. Through this extensive reach, CVS leverages its convenience and accessibility, capturing a significant share of consumer healthcare spending. However, CVS's business model doesn't stop at retail. It delves deeper into healthcare through its pharmacy benefits manager, Caremark, which provides employers and insurers with effective cost control for prescription drugs. Additionally, the landmark acquisition of Aetna, a leading health insurer, marked a strategic pivot towards vertically integrated healthcare services. This acquisition has enabled CVS not only to offer insurance products but also to streamline care with initiatives like MinuteClinics and HealthHUBs, aiming to reduce overall healthcare costs while improving patient outcomes. By intertwining its various services, CVS Health positions itself as a pioneer in the industry, standing at the intersection of healthcare delivery, pharmacy services, and insurance management, ultimately crafting synergies that aim to redefine the future of consumer health engagement.